|XGAMX -- USA Fund|| |
USD 41.26 0.29 0.71%
Mr. Arthur G. Altschul, Jr. is an Independent Director of General American Investors Company, Inc. In addition to his tenure since 1995 as a Director of the Company, Mr. Altschul is a founder and Managing Member of Diaz Altschul Capital Management, LLC and Chairman of Overbrook Management Corporationrationration and Overbrook Foundation. Mr. Altschul was the cofounder of Kolltan Pharmaceuticals, Inc. and served as Executive Chairman from Kolltans founding in 2008, until it was acquired in November 2016 by Celldex Pharmaceuticals. He served as a Director of Medicis Pharmaceutical Corporationrationration from 1992 until it was acquired by and merged into Valeant Pharmaceuticals International in December 2012. From 1992 to 1996, Mr. Altschul worked at SUGEN, Inc., a biopharmaceutical firm. Prior to 1992, Mr. Altschul worked in the Equity and Fixed Income Trading departments at Goldman, Sachs Co., was a founding limited partner of The Maximus Fund, LP, and worked in the Equity Research department at Morgan Stanley Company. Mr. Altschul serves on the Board of Directors of Child Mind Institute and is a Trustee of the Neurosciences Research Foundation
Age: 53 Director Since 1995
Altschul holds a B.S. from Columbia University in Computer Science. With his diverse business background in finance, wealth management and the pharmaceutical industry, Mr. Altschul provides the Company?s Board of Directors with valuable financial and investment expertise and an indepth understanding of the pharmaceutical industry.